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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
20.05.20 SARS-CoV-2 
infection 
protects 
against 
rechallenge in 
rhesus 
macaques 
Science/ 
article 
Monkeys that had recovered from infection 
with the new coronavirus were protected from 
re-infection, although how long the protection 
lasts is unclear. 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
20.05.20 Preliminary 
evaluation of 
COVID-19 
disease 
outcomes, test 
capacities and 
management 
preprint from 
medRxiv and 
bioRxiv (not 
peer 
reviewed) 
al/Article type 
 In this study, COVID-19 disease 
outcomes (confirmed cases, deaths 
and recoveries), testing capacities and 
disease management approaches 
among African countries were 
evaluated. 
 Egypt, South Africa, Morocco and 
Algeria were clustered as countries 
2 
approaches 
among African 
countries./URL 
with highest values of COVID-19 
disease outcomes on the continent 
during the 75-day period of 
observation. 
 The study recommends that the 
approaches adopted by the African 
countries which achieved high 
recovery rates from COVID-19 should 
be integrated into healthcare 
management plans for the disease 
across the continent even as the 
situation unfolds. 
20.05.20 Individual 
quarantine 
versus active 
monitoring of 
contacts for the 
mitigation of 
COVID-19: a 
modelling study 
The Lancet/ 
Article 
 Under what conditions can individual 
quarantine more effectively control 
COVID-19 than active monitoring? 
 This model highlights the urgent need 
for more data on the serial interval 
and the extent of presymptomatic 
transmission to make data-driven 
policy decisions regarding the cost–
benefit comparisons of individual 
quarantine versus active monitoring of 
contacts. To the extent that these 
interventions can be implemented, 
they can help mitigate the spread of 
SARS-CoV-2. 
        
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
20.05.20lic 
date 
Is Nigeria really 
on top of COVID-
19? Message 
from effective 
reproduction 
number /URL 
preprint from 
medRxiv and 
bioRxiv (not 
peer 
reviewed) 
Article type 
Research shows that control measures are 
working but not effective enough to keep 
R(t) below one. Also, the estimated 
fractional reported symptomatic cases are 
between 10 to 50%. Our analysis has shown 
evidence that the existing control measures 
are not enough to end the epidemic and 
more stringent measures are needed. 
19.05.20 Work-related 
COVID-19 
transmission in 
six Asian 
countries/areas: 
A follow-up study 
Plos One/ 
Article 
Work-related transmission is considerable in 
early COVID-19 outbreaks, and the elevated 
risk of infection was not limited to HCW. 
Implementing preventive/surveillance 
strategies for high-risk working populations 
is warranted. 
3 
Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
 20.05.20  How to 
Discover 
Antiviral 
Drugs 
Quickly 
 The New 
England 
Journal of 
Medicine/ 
Article 
Molecular-dynamics simulations together with 
virtual high-throughput screening provide a 
means of quick evaluation of existing drugs for 
antiviral activity. The authors explain how these 
methods serve in the quest for drugs to treat 
Covid-19. 
Indirect impact of COVID-19 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
20.05.20 COVID-19 in 
Uganda: 
Predicting 
the impact of 
the disease 
and public 
health 
response on 
disease 
burden 
preprint from 
medRxiv and 
bioRxiv (not 
peer 
reviewed) 
 The results indicate that COVID-19 
impact on Uganda may be relatively 
light, while there is a high risk of a 
significant negative impact on other 
disease burden if the lockdown 
response to COVID-19 is prolonged.  
 The results are likely to extend to other 
sub-Saharan populations, underlining 
the importance of tailoring COVID-19 
responses according to population 
structure and potential disease 
vulnerabilities. 
Comments, Editorials, Opinions, Blogs, News 
20.05.20 Vitamin-D and COVID-19: do deficient 
risk a poorer outcome? 
  
The Lancet Diabetes 
and Endocrinology/ In 
Focus 
Fiona Mitchell 
19.05.20 Septic shock presentation in 
adolescents with COVID-19 
The Lancet Child & 
Adolescent Health/ 
Correspondence 
Cecilia Dallan, 
Fabrizio 
Romano, 
Johan Siebert, 
Sofia Politi, 
Laurence 
4 
Lacroix, Cyril 
Sahyoun 
18.05.20 How covid-19 is accelerating the 
threat of antimicrobial resistance 
BMJ/ Opinion Jeremy Hsu 
19.05.20 Coronavirus vaccine trials have 
delivered their first results — but their 
promise is still unclear 
Nature/ News Ewen 
Callaway 
21.05.20 Africa: Let's Prepare for a Marathon 
Struggle Against COVID-19 
  
All Africa Dr Chibuzo 
Okonta 
20.05.20 South Africa: Why Easing the 
Lockdown Threatens to Put Workers 
in South Africa At Risk  
All Africa   
21.05.20 South Africa: SAMRC Scientists 
Harvest Live Coronavirus for 
Validation of Test Kits 
All Africa   
21.05.20 South Sudan: Minister Makuei Tests 
Positive for COVID-19 
All Africa   
21.05.20 Africa: COVID-19 'Is an African 
Governance Crisis' 
All Africa   
20.05.20 Global solidarity with Africa is an 
imperative 
UN brief   
20.05.20 How Academic Health Systems Can 
Move Forward Once COVID-19 
Wanes 
JAMA/ viewpoint Steven D. 
Shapiro, Paul 
B. Rothman 
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Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
 20.05.20  Impact of 
COVID-19 in 
Africa 
 UN 
Policy 
Brief 
 This policy brief takes a snapshot of 
immediate impacts of the pandemic 
on health, economies, peace, 
security, human rights and 
humanitarian assistance in Africa. 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence 
& policy 
maps 
Current 
research 
including trials 
  Diagnosti
cs 
  Treatment
s 
  Vaccin
es 
WHO 
sitreps 
WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-
CoV-2 Test 
Tracker 
  Global 
COVID-19 
Clinical 
Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Argumen
ts 
Indonesi
a 
EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-
CoV-2 
Diagnostic
s: 
performanc
e data 
  US NIH 
registered 
clinical 
trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
Europea
n CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based 
tests for 
COVID-19 
  Solidarity 
trial 
 COVID-
19 
Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford 
C19 
Governme
nt 
Response 
US NIH  Our World 
in Data: 
C19 
Testing 
  COVID-
19 
Therapeuti
cs 
Accelerator 
  
6 
Tracker 
(OxCGRT) 
Our World 
in Data 
  Singapor
e 
 Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 
5050 
  UK   Cochrane       
CEBM, 
University 
of Oxford 
  US   Clinicaltrials.g
ov 
      
Humanitari
an Data 
Exchange 
       UKCDR       
Information 
is Beautiful 
              
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
  
7 
C19 Resource Hubs 
Global  Region
al & 
Country 
Academi
c journals 
& 
Publisher
s 
Global Health 
Institutes/Centres/Funders/O
ther 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa 
CDC 
Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communicatio
n 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin 
of the 
WHO 
ICL MRC Centre for Global 
Infectious Disease Analysis  
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll
: SSA 
Cambridg
e 
Universit
y Press 
ODI SLH: 
Handwashi
ng in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Response 
Fund 
Global 
Health 
Network 
Africa 
Cell 
Press 
Johns Hopkins University 
 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academ
y of 
Science
s 
Cochrane  Center for Global 
Development 
    Social 
Developme
nt Direct 
C19 blog 
series 
UN Women Africa 
Evidenc
e 
Network 
Elsevier CMMID Repository     
8 
UNOCHA OCHA 
Souther
n and 
Eastern 
Africa 
COVID-
19 
Digest 
JAMA 
Network 
Norwegian Institute of Public 
Health 
    
UNHCR   The 
Lancet 
Oxford Centre for Evidence-
based Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints
) 
 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
Universit
y Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
      
World Bank   Science       
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David 
Nabarro 
  SSRN 
(Preprints
)  
      
Reliefweb   Wiley       
9 
Humanitarian 
OpenStreetM
ap Team 
          
Global 
Partnership 
for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
10 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
11 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
  
12 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
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